COMMUNIQUÉ DE PRESSE
News
-
-
COMMUNIQUÉ DE PRESSE
EUROPLASMA: Information relative au nombre total de droits de vote et d’actions composant le capital au 31 janvier 2024
EUROPLASMA déclare le nombre total de droits de vote et d'actions au 31 janvier 2024 conformément aux réglementations en vigueur. L'entreprise propose des solutions innovantes pour le traitement et la valorisation des déchets dangereux -
-
COMMUNIQUÉ DE PRESSE
SOWITEC and Cubico Sustainable Investments sign contract for the development of renewable energy projects in Mexico with a capacity of 800 MW
SOWITEC and Cubico Sustainable Investments sign contract for 800 MW renewable energy projects in Mexico, including wind and solar projects, with secured land and permits. The agreement reflects SOWITEC's long-term market potential in the region and Cubico's commitment to reducing greenhouse gas emissions and driving economic growth in Mexico -
-
COMMUNIQUÉ DE PRESSE
Original-Research: Rubean AG (von NuWays AG): BUY
Rubean AG has reported a record-breaking monthly turnover in January 2024, driven by a significant increase in user numbers and contract work. This performance is expected to lead to strong sales growth and potential positive newsflow from new partnerships in the coming months -
-
COMMUNIQUÉ DE PRESSE
Original-Research: Cantourage Group SE (von NuWays AG): BUY
Cantourage Group SE receives a buy rating with a target price of €11, following the approval of the 'Cannabis Act' in Germany, expected to take effect on April 1st. The act will allow adults to possess cannabis and establish non-profit cannabis clubs, benefiting established players like Cantourage -
COMMUNIQUÉ DE PRESSE
u-blox introduces new LTE-M modules with integrated GNSS to boost industrial connectivity
u-blox introduces new LTE-M modules with integrated GNSS for industrial connectivity. The SARA-R52 and LEXI-R52 series, based on the u-blox UBX-R52 cellular chip, offer concurrent positioning and wireless communication tailored for IoT use cases -
COMMUNIQUÉ DE PRESSE
AATec Medical starts collaboration with the German Federal Agency for Disruptive Innovation SPRIND for alpha-1 antitrypsin
AATec Medical collaborates with German Federal Agency for Disruptive Innovation SPRIND to develop ATL-105, a recombinant alpha-1 antitrypsin platform for respiratory diseases, including viral infections and inflammatory diseases
